Patent · US Active

Anti-GM-CSF antibodies and uses thereof

US10889641B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

I-Mab Biopharma Co., Ltd. · CN

Inventors

Zhengyi Wang · Shanghai, CN
Lei Fang · Katy, US
Bingshi Guo · Shanghai, CN
Jingwu Zang · Shanghai, CN

Key dates

Filing date	Aug 9, 2018
Grant date	Jan 12, 2021
Priority date	—
Expiry date	Dec 2, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/535
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.